Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis Stanley CohenJeffrey R. CurtisViatcheslav R. Akmaev Commentary Open access 27 November 2022 Pages: 1 - 6
Systematic Literature Review and Meta-analysis of Venous Thromboembolism Events in Systemic Lupus Erythematosus Natalia BelloKristin Joy MeyersRicard Cervera Review Open access 06 December 2022 Pages: 7 - 34
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis Bernard CombeRobin BesuyenMaya H. Buch Original Research Open access 07 October 2022 Pages: 35 - 51
Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study Bernard G. CombeYoshiya TanakaDaniel Aletaha Original Research Open access 09 October 2022 Pages: 53 - 70
Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study Bernard G. CombeYoshiya TanakaDaniel Aletaha Correction Open access 04 January 2023 Pages: 71 - 72
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis Rieke AltenGerd R. BurmesterBruno Fautrel Original Research Open access 13 October 2022 Pages: 73 - 93
Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses Kimberly RaymondStephen MaherKerry Gairy Original Research Open access 13 October 2022 Pages: 95 - 115
Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA) Siegfried WassenbergRolf RauPeter-Andreas Löschmann Original Research Open access 17 October 2022 Pages: 117 - 133
Discrepancy in Metabolic Syndrome between Psoriatic Arthritis and Rheumatoid Arthritis: a Direct Comparison of Two Cohorts in One Center Borui LiHong HuangZhuoli Zhang Original Research Open access 20 October 2022 Pages: 135 - 148
Serum Calprotectin as a Promising Inflammatory Biomarker in Psoriatic Arthritis: a 1-Year Longitudinal Study Borui LiGuangtao LiZhuoli Zhang Original Research Open access 21 October 2022 Pages: 149 - 160
Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials Yoshiya TanakaTatsuya AtsumiTsutomu Takeuchi Original Research Open access 03 November 2022 Pages: 161 - 185
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry Martin J. BergmanPatrick ZuegerAlexis Ogdie Original Research Open access 04 November 2022 Pages: 187 - 199
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases Claudia A. SalinasAnthony Louderthe B023 Study Consortium Original Research Open access 13 November 2022 Pages: 201 - 223
Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO Cohort Sara BaydounSandrine Jousse-JoulinValérie Devauchelle-Pensec Original Research Open access 23 November 2022 Pages: 225 - 238
Causal Effect of Higher Glycated Hemoglobin (HbA1c) Levels on Knee Osteoarthritis Risk: A Mendelian Randomization Study Lirong ChenChao JiaHuiqin Yang Original Research Open access 01 December 2022 Pages: 239 - 247
COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization Hossein AziziHanie KarimiMaryam Masoumi Original Research Open access 02 December 2022 Pages: 249 - 259
A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA Christopher F. BellShirley P. HuangDaniel J. Wallace Original Research Open access 05 December 2022 Pages: 261 - 274
Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study Iain B. McInnesKoji KatoPeter Wung Brief Report Open access 15 October 2022 Pages: 275 - 292
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report Zhang YeRu JinliZhang Jinxiu Case Report Open access 29 November 2022 Pages: 293 - 300
